您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Chinese Heparin derivatives market

讯：

Research report of Chinese Heparin derivatives market

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$1,500 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com   


Brief introduction:
   Drugs of Heparin derivatives are import anticoagulants (direct
 anticoagulant), of which low molecular weight heparin sodium and
 low molecular weight heparin calcium are the mainstream products.
 In global market key brands include: Pfizer's "Fragmin", Sanofi-
Avetnis's "Clexane" and "Fraxiparine" etc.
   The report presents the market size and development trend of
 Heparin derivatives, the sales values of different products,
 competitive manufacturers in China. The report also provides
 market forecasts and competitive and opportunity analysis in
 China. 


The table of contents
1、Summary
2、Overview of blood thinning drugs
  2.1 Anticoagulant Drugs
  2.2 Antiplatelet drugs
  2.3 Others of Anticoagulant or Antiplatelet drugs
  2.4 Thrombolysis drugs
3 Sales analysis of blood thinning drugs in the past 4 years
  3.1 Market scale and growth trend
  3.2 Market share and change trend
    3.2.1 Sales shares of different products of Blood Thinning Drugs
    3.2.2 Sales shares of different products of Antiplatelet drugs
    3.2.3  Sales shares of different products of Anticoagulant Drugs
    3.2.4 Sales shares of different products of Thrombolysis drugs
  3.3 Change about sales rank of key brands
4 Market analysis of Heparin derivatives in 2005
  4.1 Sales situation Heparin derivatives and other blood thinning
 drugs in 2005
  4.2 Market shares of different categories of blood thinning drugs
 in 2005
  4.3 Analysis about key manufacturers
     Low molecular weight heparin sodium 
     Low molecular weight heparin calcium
     Heparin sodium
     Heparin calium
5 Sales analysis of Heparin derivatives
6 Situation on global new drug research of blood thinning drugs
  6.1 Antiplatelet drugs
  6.2 Anticoagulant Drugs
7 Research and development in China
  7.1 List of Domestic marketd products and import procucts
  7.2 Status of application and approval for Blood Thinning Drugs